Crohn’s is an autoimmune disorder that causes inflammation and damage to the gastrointestinal (GI) tract, according to the U.S. Centers for Disease Control and Prevention. Crohn’s disease may ...
Crohns Disease is a chronic inflammatory bowel condition that primarily affects the digestive tract but can also cause ...
An investigational oral Janus kinase (JAK) inhibitor failed to meet most primary endpoints in a phase III trial of patients ...
The chronic condition can cause abdominal pain, diarrhea, bloody stools and fatigue. New research suggests it affects more ...
Results of a Phase III study conducted by an international team of researchers reveal that mirikizumab is more effective and ...
The SELECTION study1 showed that the JAK 1 inhibitor filgotinib is safe and efficacious in ulcerative colitis. Based on positive results of the phase 2 FITZROY study2 in Crohn's disease, it was ...
Inflammatory bowel disease (IBD) affects an estimated 1.6 million Americans. In fact, there are more than 70,000 new cases of ...
DelveInsight's "Crohn’s Disease Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth ...